C-Reactive Protein and Endothelial Dysfunction in Women With Glucose Intolerance
This trial is active, not recruiting.
|Start date||January 2002|
|End date||June 2003|
|Trial size||46 participants|
|Trial identifier||NCT00589355, 12110|
The goal of this study is to determine whether markers of vascular inflammation (such as c-reactive protein) can predict endothelial dysfunction (as measured by flow-mediated dilation) in postmenopausal women with glucose intolerance compared to normal controls.
|Observational model||case control|
postmenopausal women with glucose intolerance (either pre-diabetes or diet-controlled diabetes)
postmenopausal women with normal glucose tolerance
time frame: performed after screening evaluation
flow-mediated dilation of brachial artery
time frame: performed twice after screening visit
time frame: performed after screening visit
Female participants from 40 years up to 65 years old.
Inclusion Criteria: - healthy postmenopausal women - ages 40-65 Exclusion Criteria: - smokers - diabetes requiring medication
|Official title||C-Reactive Protein and Endothelial Dysfunction in Women With Glucose Intolerance|
|Principal investigator||Barbara I Gulanski, MD, MPH|
Call for more information